Yu-Xiao Yang

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 20

Top Topics

Colorectal Cancer Screening

Clinical Decision Support

Top Venues

Pharmacoepidemiology and drug safety

The American journal of gastroenterology

Digestive diseases and sciences

Annals of internal medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. The American journal of gastroenterology (2024)
Timothy J Brown, Phyllis A Gimotty, Ronac Mamtani, Thomas Benjamin Karasic, Yu-Xiao Yang
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO clinical cancer informatics 8 (2024)
Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. The American journal of gastroenterology (2024)
Robert Lam, Wei-Ting Hwang, Sumanth Chennareddy, Ben Boursi, Yu-Xiao Yang
Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus. Digestive diseases and sciences 69 (5) (2024)
Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness of Tofacitinib in Patients With Ulcerative Colitis: A Nationwide Veterans Administration Cohort Study. The American journal of gastroenterology (2024)
Timothy J Brown, Phyllis A Gimotty, Ronac Mamtani, Thomas Benjamin Karasic, Yu-Xiao Yang
Classification and Regression Trees to Predict for Survival for Patients With Hepatocellular Carcinoma Treated With Atezolizumab and Bevacizumab. JCO clinical cancer informatics 8 (2024)
Robert Lam, Wei-Ting Hwang, Sumanth Chennareddy, Ben Boursi, Yu-Xiao Yang
Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus. Digestive diseases and sciences 69 (5) (2024)
Nabeel Khan, Ramaswamy Sundararajan, Manthankumar Patel, Chinmay Trivedi, Yu-Xiao Yang
Effectiveness Of Tofacitinib In Ulcerative Colitis Patients: A Nationwide Veterans Administration Cohort study. The American journal of gastroenterology (2024)
Robert Lam, Wei-Ting Hwang, Sumanth Chennareddy, Ben Boursi, Yu-Xiao Yang
Exogenous Insulin Therapy Is Associated with the Risk of Advanced Colorectal Adenoma in Patients with Diabetes Mellitus. Digestive diseases and sciences (2024)
Pilar Hernandez-Con, Justine Shults, Allison W Willis, Yu-Xiao Yang
Dopamine Agonists and Risk of Lung Cancer in Patients with Restless Legs Syndrome. Pharmacoepidemiology and drug safety (2023)
Michael Bretthauer, Yu-Xiao Yang
New American College of Physicians Guidance on Colorectal Cancer Screening: Less Is More. Annals of internal medicine (2023)
Pilar Hernandez-Con, Justine Shults, Allison W Willis, Yu-Xiao Yang
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiology and drug safety (2023)
Christine Laine, Christina C Wee, Stephanie Chang, Deborah Cotton, Vineet Chopra, Sankey V Williams, Yu-Xiao Yang, Eliseo Guallar, Eric A Ross
Medical Masks Versus N95 Respirators for Preventing COVID-19 Among Health Care Workers. Annals of internal medicine 176 (7) (2023)
Timothy J Brown, Ronac Mamtani, Phyllis A Gimotty, Thomas Benjamin Karasic, Yu-Xiao Yang
Outcomes of hepatocellular carcinoma by etiology with first-line atezolizumab and bevacizumab: a real-world analysis. Journal of cancer research and clinical oncology (2023)
Pilar Hernandez-Con, Justine Shults, Allison W Willis, Yu-Xiao Yang
Dopamine agonists and risk of lung cancer in patients with restless legs syndrome. Pharmacoepidemiology and drug safety (2023)
Louise L Wang, Alyssa A Grimshaw, Catherine Mezzacappa, Navid Rahimi Larki, Yu-Xiao Yang, Amy C Justice
Do polygenic risk scores add to clinical data in predicting pancreatic cancer? a scoping review. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Louise L Wang, Jane Dobkin, Sanjay Salgado, David E Kaplan, Yu-Xiao Yang
Development and validation of case-finding algorithms to identify acute pancreatitis in the Veterans Health Administration. Pharmacoepidemiology and drug safety 31 (12) (2022)
Nabeel Khan, Yu-Xiao Yang
Letter: screening for infectious side effects in patients with IBD-the importance and potential of real-world remote monitoring. Authors' reply. Alimentary pharmacology & therapeutics 55 (2) (2022)
Nabeel Khan, Dhruvan Patel, Chinmay Trivedi, Tyler Pernes, Himanshu Kavani, Dawei Xie, Yu-Xiao Yang
The impact of IBD medications on risk of pneumonia and pneumonia-related hospitalisation: a nationwide cohort study of 56 410 IBD patients. Alimentary pharmacology & therapeutics (2021)
Akram Saad, Jeffrey Goldstein, Ofer Margalit, Einat Shacham-Shmueli, Yaacov R Lawrence, Yu-Xiao Yang, Kim A Reiss, Talia Golan, Ronac Mamtani, Naama Halpern, Dan Aderka, Meir Mouallem, Adam Goldstein, Bruce Giantonio, Ben Boursi
Assessing the effects of beta-blockers on pancreatic cancer risk: A nested case-control study. Pharmacoepidemiology and drug safety 29 (5) (2020)